Please assess the completion status of the following clinical trial:

Trial Title: Research Study of Greater Occipital Nerve Block As A Treatment For Prolonged Migraine Attacks

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects, male or female, between the ages of 18 and 80 years old (inclusive) with a previous diagnosis fulfilling IHS criteria for episodic migraine~* Presenting to clinic in migraine status, meaning the migraine has continued for greater than or equal to 3 days but less than 3 months.~* Pain must be reported as at least moderate pain level at time of injections~Exclusion Criteria:~A subject is ineligible to participate in this study if he/she satisfies any of the following criteria:~* Subjects who have received greater occipital nerve blocks in the past~* Subjects who in their own or the investigator's opinion are unable to describe their symptoms~* Subjects who are pregnant or lactating

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Lidocaine/Bupivicaine (Type: ACTIVE_COMPARATOR): None
- saline (Type: PLACEBO_COMPARATOR): matching volume of saline injected

Based on this trial design, predict the completion outcome and termination type (if applicable).